Our Medical Experts
Max Healthcare is home to 5000 eminent doctors in the world, most of whom are pioneers in their respective fields. Additionally, they are renowned for developing innovative and revolutionary clinical procedures.
Find a DoctorDelhi/NCR:
Mohali:
Dehradun:
Bathinda:
Mumbai:
Nagpur:
Lucknow:
BRAIN ATTACK:
To Book an Appointment
Call Us+91 92688 80303Uterine cancer, a critical concern in women's health, requires specialised medical treatment and comprehensive care. At Max Hospital, one of the uterus cancer hospitals in Delhi, India, we are acutely aware of the challenges posed by uterine cancer and are dedicated to providing exceptional care tailored to this condition. Our commitment extends to offering advanced therapies and surgical techniques specific to gynecologic oncology, while also ensuring a supportive and compassionate environment for our patients. Our team includes highly skilled gynecologic oncologists who excel in the diagnosis and treatment of uterine adenocarcinoma cancer, and other related gynaecological conditions, including uterine polyps and adenomyosis uterine. We prioritise your journey to recovery, stand with you in your fight against uterine cancer, and strive for the best possible outcomes with the utmost dedication and care.
Uterine cancer is a type of cancer that happens in the uterus. There are two main kinds:
The staging is done using the FIGO system, which outlines the extent of cancer spread.
Stage I: Cancer is confined to the uterus or womb, without extending to other body parts.
Stage II: Cancer has extended from the uterus to the cervical stroma, the supportive tissue surrounding the cervix, but has not reached other body areas.
Stage III: Cancer has progressed beyond the uterus but remains within the pelvic region.
Stage IV: Cancer has metastasized, affecting the rectum, bladder, or distant organs.
This type of cancer is also categorised by its grade (G), which is determined by how much the cancer cells resemble normal cells under microscopic examination.
When assessing the grade, doctors compare cancerous tissue with normal tissue. Normal tissue typically has a diverse mix of cell types arranged together. If the cancerous tissue resembles normal tissue with varied cell arrangements, it's termed "differentiated" or a "low-grade tumour." Conversely, if the cancerous tissue significantly differs from normal tissue, it's described as "poorly differentiated" or a "high-grade tumour." The grade of the cancer can indicate how rapidly the cancer might grow. Generally, slower-growing cancers have a more favourable prognosis.
Uterine cancer is graded using the letter "G":
The signs and symptoms of uterine cancer can vary, but here are some common ones:
The precise cause of uterine cancer remains unclear to researchers. It is believed that a series of changes occur in the uterus cells, leading these cells to mutate. These mutated cells then grow and multiply uncontrollably, potentially forming a mass known as a tumour.
There are specific risk factors that may elevate the likelihood of developing uterine cancer. If you are considered to be at a higher risk, it's important to discuss with your uterine cancer doctors in Delhi or elsewhere about measures you can take to safeguard your health.
Factors that increase the risk of uterine cancer include:
Diagnosing uterine cancer involves a series of tests:
A doctor might examine the abdomen for swelling. They may also perform an internal examination, either by placing two fingers inside the vagina while pressing on the abdomen or using a speculum to widen the vaginal walls, similar to a cervical screening test.
This test uses sound waves to create images of the uterus and ovaries. The sound waves produce echoes when they encounter dense structures like tumours or organs, which a computer then converts into images. A pelvic ultrasound often includes both external and internal exams and typically lasts 15 to 30 minutes. If anything unusual is detected, a biopsy might be recommended.
Conducted in a specialist's office, this involves inserting a thin tube into the vagina to collect cells from the uterine lining. These cells are then examined microscopically. Patients may experience discomfort similar to menstrual cramps and might be advised to take anti-inflammatory medication beforehand.
A hysteroscope, a telescope-like device, is inserted through the vagina into the uterus, allowing a gynaecologist to view the inside of the uterus. Tissue can also be removed during this procedure for further testing.
These tests help assess overall health and guide treatment planning.
If uterine cancer is confirmed, further scans like X-rays, CT, MRI, or PET scans (especially for types like sarcoma) may be conducted to check if the cancer has spread to other body parts.
Most people with uterine cancer need surgery. The particular treatment plan depends on the type of cancer and the patient’s overall health.
One of the most common treatments is a hysterectomy; it is a procedure wherein the uterus is removed if enquired the surgery also removes the ovaries and fallopian tubes and addresses the draining lymph nodes by either sentinel lymph node excision or complete lymphadenectomy depending on a case-to-case scenario.
Uterine cancer may cause abnormal vaginal discharge or bleeding, particularly after menopause or between periods. Other symptoms include pain or pressure in the pelvis. It's important to see a doctor if you experience any unusual bleeding, especially after menopause.
Uterine cancer, especially its most common form, uterine cancer, is often curable when caught early. Treatments include surgery, radiation therapy, chemotherapy, and other therapies. Uterine sarcomas are more aggressive and harder to treat, but they are rarer.
The survival rates for uterine cancer vary based on the stage of the cancer. The 5-year relative survival rates are 96% for localised, 72% for regional, and 20% for distant stages. It's important to note that these numbers are based on people diagnosed between 2012 and 2018 and only apply to the stage of the cancer when first diagnosed.
Uterine fibroids are noncancerous tumours that grow in the uterus, often during childbearing years. They are not the same as uterine cancer, which involves the uncontrolled growth of cancerous cells in the uterus. Uterine fibroids are generally benign, while uterine cancer requires medical intervention.
Uterine cancer is a type of uterine cancer that begins in the endometrium, the lining of the uterus. However, uterine cancer can also refer to other types, including uterine sarcoma, which starts in the muscles or other tissues of the uterus.
As mentioned in response to question 3, the 5-year relative survival rates for uterine cancer are 96% for localised, 72% for regional, and 20% for distant stages.
A Pap test, primarily used to detect cervical cancer, is not typically used to diagnose uterine cancer. It involves collecting cells from the cervix, not the uterus. For uterine cancer, other diagnostic methods like pelvic exams, ultrasounds, and biopsies of the uterine lining are more relevant. However, in some cases, a Pap test might incidentally reveal abnormal cells that could suggest further investigation is needed for potential uterine cancer.
The rate at which uterine cancer spreads can vary depending on the type and stage of the cancer. Uterine cancer, the most common type of uterine cancer, generally has a slower progression compared to more aggressive forms like uterine sarcoma. However, without treatment, any cancer has the potential to spread more rapidly. Early detection and treatment are crucial in managing the spread of uterine cancer effectively.
Endometrial cancer is most commonly diagnosed in postmenopausal women, typically between the ages of 55 and 64. It's rare in women under 45. The risk increases with age, as most cases occur in women who have undergone menopause. Factors such as hormone changes, obesity, and genetics can influence the age of onset and risk of developing endometrial cancer.
Reviewed By Dr. Alka Dahiya - Consultant - Cancer Care / Oncology, Surgical Oncology, Gynecologic Oncology, Robotic Surgery, Breast Cancer on 30 Sept 2024.
Max Healthcare is home to 5000 eminent doctors in the world, most of whom are pioneers in their respective fields. Additionally, they are renowned for developing innovative and revolutionary clinical procedures.
Max Healthcare is home to 5000 eminent doctors in the world, most of whom are pioneers in their respective fields. Additionally, they are renowned for developing innovative and revolutionary clinical procedures.
Find a Doctor